Omnicell, Inc. (NASDAQ:OMCL) will be discussing 3Q20 financial results with the investment community.on 27th October 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.omnicell.com
Earnings Expectation
Omnicell, Inc. is set to announce third quarter earning results on Tuesday 27th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, OMCL to report 3Q20 income of $ 0.49 per share. For the full year, analysts anticipate top line of $ 874.11 million, while looking forward to income of $ 2.24 per share bottom line.
The Company Outlook
Earnings for 3Q20 are anticipated in a range of $ 0.44 ~ $ 0.52 per share, while revenues are expected in a range of $ 204.00 million ~ $ 212.00 million
Full Year 2020 topline are forecasted in a range of$ 1,000.00 million ~ $ 1,020.00 million, where as bottomline are predicted in a range of $ 2.96 ~ $ 3.16 per share
Click Here For More Historical Outlooks Of Omnicell, Inc.
Omnicell, Inc. provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence.
